Teresa H Evering1, Allison Applebaum, Melissa La Mar, Donald Garmon, David Dorfman, Martin Markowitz. 1. aAaron Diamond AIDS Research Center, an affiliate of the Rockefeller University bMemorial Sloan-Kettering Cancer Center cIcahn School of Medicine at Mount Sinai, New York, New York, USA. *Current address for Donald Garmon: Columbia University Medical Center, New York, New York, United States of America.
Abstract
OBJECTIVE: To determine the prevalence of HIV-associated neurocognitive disorders (HAND) in HIV-infected participants who initiated combination antiretroviral therapy (cART) during primary infection. DESIGN: Cross-sectional observational study. METHODS: HIV-infected men without neuropsychiatric confounds who had initiated cART during primary infection were administered a neuropsychological battery as well as questionnaires evaluating depression and quality of life. Eligibility was determined by a medical examination with history and review of records. RESULTS: Twenty-six primarily non-Hispanic white (73%), male (100%) participants were enrolled and underwent neurocognitive assessment. Mean age was 44 (28-71) years, with a median of 17 years of education (13-24). Median current and nadir CD4 T-cell counts were 828 (506-1411) and 359 (150-621) cells/μl. All participants had plasma HIV-1 RNA less than 50 copies/ml. Median duration of cART prior to enrolment was 5.7 years (2.2-9.9). Median global deficit score was 0.17 (0.00-0.60). Only one (4%) participant was impaired. CONCLUSION: Rates of HAND in this cohort of HIV-infected men without comorbid conditions who initiated early cART are low. Our findings suggest a possible neuroprotective benefit of early cART and an important contribution of comorbidities to observed HAND prevalence.
OBJECTIVE: To determine the prevalence of HIV-associated neurocognitive disorders (HAND) in HIV-infectedparticipants who initiated combination antiretroviral therapy (cART) during primary infection. DESIGN: Cross-sectional observational study. METHODS:HIV-infectedmen without neuropsychiatric confounds who had initiated cART during primary infection were administered a neuropsychological battery as well as questionnaires evaluating depression and quality of life. Eligibility was determined by a medical examination with history and review of records. RESULTS: Twenty-six primarily non-Hispanic white (73%), male (100%) participants were enrolled and underwent neurocognitive assessment. Mean age was 44 (28-71) years, with a median of 17 years of education (13-24). Median current and nadir CD4 T-cell counts were 828 (506-1411) and 359 (150-621) cells/μl. All participantshad plasma HIV-1 RNA less than 50 copies/ml. Median duration of cART prior to enrolment was 5.7 years (2.2-9.9). Median global deficit score was 0.17 (0.00-0.60). Only one (4%) participant was impaired. CONCLUSION: Rates of HAND in this cohort of HIV-infectedmen without comorbid conditions who initiated early cART are low. Our findings suggest a possible neuroprotective benefit of early cART and an important contribution of comorbidities to observed HAND prevalence.
Authors: Ronald J Ellis; Scott Letendre; Florin Vaida; Richard Haubrich; Robert K Heaton; Ned Sacktor; David B Clifford; Brookie M Best; Susanne May; Anya Umlauf; Mariana Cherner; Chelsea Sanders; Craig Ballard; David M Simpson; Cheryl Jay; J Allen McCutchan Journal: Clin Infect Dis Date: 2013-12-18 Impact factor: 9.079
Authors: Igor Grant; Donald R Franklin; Reena Deutsch; Steven P Woods; Florin Vaida; Ronald J Ellis; Scott L Letendre; Thomas D Marcotte; J H Atkinson; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; John A McCutchan; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Davey M Smith; Robert K Heaton Journal: Neurology Date: 2014-05-09 Impact factor: 9.910
Authors: Kevin R Robertson; Marlene Smurzynski; Thomas D Parsons; Kunling Wu; Ronald J Bosch; Julia Wu; Justin C McArthur; Ann C Collier; Scott R Evans; Ron J Ellis Journal: AIDS Date: 2007-09-12 Impact factor: 4.177
Authors: Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis Journal: Arch Neurol Date: 2008-01
Authors: Denise C Hsu; Piyanate Sunyakumthorn; Matthew Wegner; Alexandra Schuetz; Decha Silsorn; Jacob D Estes; Claire Deleage; Khamis Tomusange; Samir K Lakhashe; Ruth M Ruprecht; Eric Lombardini; Rawiwan Im-Erbsin; Yanin Kuncharin; Yuwadee Phuang-Ngern; Dutsadee Inthawong; Weerawan Chuenarom; Robin Burke; Merlin L Robb; Lishomwa C Ndhlovu; Jintanat Ananworanich; Victor Valcour; Robert J O'Connell; Serena Spudich; Nelson L Michael; Sandhya Vasan Journal: J Virol Date: 2018-05-14 Impact factor: 5.103